Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR (Exact name of registrant as specified in its charter) Delaware 04-2314970 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran ...

Group 1 - UFP Technologies, Inc. will participate in the Raymond James 47th Annual Institutional Investors Conference in Orlando, Florida from March 1-4, 2026, with a presentation scheduled for March 3 at 2:50 PM [1] - The company specializes in contract development and manufacturing of single-use and single-patient medical devices, serving as a crucial link in the medical device supply chain [2] - UFP Technologies is a valued outsourcing partner for leading medical device manufacturers, providing components for various applications including minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants [2]

UFP Technologies (NasdaqCM:UFPT) Q4 2025 Earnings call February 25, 2026 08:30 AM ET Company ParticipantsAndrew Cooper - Director of Equity ResearchJeff Bailly - Chairman and CEOJustin Ages - Director of Equity ResearchRon Lataille - VP, Treasurer, and CFOConference Call ParticipantsMax Michaelis - Equity Research AnalystNone - AnalystOperatorGood day, welcome to the UFP Technologies fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, pleas ...

UFP Technologies (NasdaqCM:UFPT) Q4 2025 Earnings call February 25, 2026 08:30 AM ET Company ParticipantsAndrew Cooper - Director of Equity ResearchJeff Bailly - Chairman and CEOJustin Ages - Director of Equity ResearchRon Lataille - VP, Treasurer, and CFOConference Call ParticipantsMax Michaelis - Equity Research AnalystNone - AnalystOperatorGood day, welcome to the UFP Technologies fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, pleas ...

UFP Technologies (NasdaqCM:UFPT) Q4 2025 Earnings call February 25, 2026 08:30 AM ET Speaker3Good day, welcome to the UFP Technologies fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on your telephone keypad. To withdraw your question, pleas ...

分组1 - UFP Technologies reported quarterly earnings of $2.44 per share, exceeding the Zacks Consensus Estimate of $2.26 per share, with a year-over-year comparison showing a slight decrease from $2.46 per share [1] - The company achieved an earnings surprise of +7.81% for the quarter, following a previous surprise of +7.66% when it reported earnings of $2.39 per share against an expectation of $2.22 per share [1][2] - UFP's revenues for the quarter were $148.92 million, which fell short of the Zacks Consensus Estimate by 1.08%, but showed an increase from $144.07 million in the same quarter last year [2] 分组2 - The stock has gained approximately 8.9% since the beginning of the year, contrasting with a 0.1% decline in the S&P 500 [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $2.55 on revenues of $156.63 million, and for the current fiscal year, it is $10.58 on revenues of $635.48 million [7] 分组3 - The Medical - Instruments industry, to which UFP belongs, is currently ranked in the top 29% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - UFP currently holds a Zacks Rank of 3 (Hold), suggesting that the stock is expected to perform in line with the market in the near future [6]

UFP Technologies Announces Record 2025 Results Newburyport, Mass., February 24, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported 2025 net income of $68.3 million, 15.8% higher than net income of $59.0 million for 2024. Adjusted net income grew 12.7% to $76.1 million. Net sales for the year ended December 31, 2025 were $602.8 million, 19.5% higher than 2024 sales of $504.4 milli ...

NEWBURYPORT, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported 2025 net income of $68.3 million, 15.8% higher than net income of $59.0 million for 2024. Adjusted net income grew 12.7% to $76.1 million. Net sales for the year ended December 31, 2025 were $602.8 million, 19.5% higher than 2024 sales of $504.4 million. GAAP and adjusted earnings p ...

UFP Industries Announces Fourth Quarter 2025 Results [Accessibility Statement] Skip NavigationGRAND RAPIDS, Mich., Feb. 23, 2026 /PRNewswire/ -- UFP Industries, Inc. (Nasdaq: UFPI) a leading manufacturer focused on delivering value-added products across its Retail, Packaging, and Construction segments reported results for the fourth quarter 2025.- Cash flows from operating activities in 2025 was $546 million. Free cash flow1 of $451 million was used to repurchase nearly $450 million of our shares.- New prod ...

Core Viewpoint - UFP Technologies, Inc. is set to report its fourth quarter and year-end results on February 24, 2026, with a conference call scheduled for February 25, 2026, at 8:30 AM ET to discuss these results [1][2]. Company Overview - UFP Technologies, Inc. is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices [3]. - The company plays a crucial role in the medical device supply chain and serves as a valued outsourcing partner for leading medical device manufacturers [3]. - Its products are utilized in various medical applications, including minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants [3].